|
|
||||||||
Neuroradiology |
1 From the Departments of Radiology (S.C., D.C.S., A.D.A.) and Neurology (D.J.L., L.P.R.), Neurological Institute of New York, Columbia University, Milstein Hospital Bldg, 3rd Floor, 177 Fort Washington Ave, New York, NY 10032. Received July 16, 1998; revision requested August 12; revision received November 17; accepted January 27, 1999. S.C. supported by an RSNA Scholars Award and a General Electric-AUR Radiology Research Academic Fellowship. D.C.S. supported by an R-29 award from the National Institute of Neurological Disorders and Stroke (National Institutes of Health). Address reprint requests to S.C.
PURPOSE: To evaluate single-voxel proton magnetic resonance (MR) spectroscopy in detection of abnormality of the upper motor neuron in patients with motor neuron diseases.
MATERIALS AND METHODS: In 43 of 50 patients with motor neuron disease and 14 of 14 control subjects, matching sets of MR spectra were obtained in the left and right motor cortex. The ratio of N-acetylaspartate (NAA) to creatine (Cr) was derived from peak area measurements. Mean ratios were calculated for control subjects and several patient groups, including patients with amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis (PLS). MR images were evaluated for corticospinal tract hyperintensity and central sulcus dilatation.
RESULTS: Mean NAA/Cr values were significantly different between control subjects and the ALS or PLS groups (P < .05). With an optimal cutoff of 2.5, NAA/Cr values were abnormal in 15 (79%) of 19 patients with ALS, 12 (67%) of 18 patients with PLS, and one (7%) of 14 control subjects. Corticospinal tract hyperintensity, central sulcus enlargement, or both were found in 43% of the ALS group, 24% of the PLS group, and 7% of the control group.
CONCLUSION: NAA/Cr values determined at single-voxel proton MR spectroscopy are more sensitive than are standard findings at MR imaging in the detection of upper motor neuron disease.
Index terms: Amyotrophic lateral sclerosis, 13.89 Brain, cortex, 13.89 Brain, diseases, 13.89 Brain, MR, 13.121411, 13.121412, 13.121416, 13.12145 Magnetic resonance (MR), comparative studies, 13.121411, 13.121412, 13.121416, 13.12145 Magnetic resonance (MR), spectroscopy, 13.12145
This article has been cited by other articles:
![]() |
H. Mitsumoto, A. M. Ulug, S. L. Pullman, C. L. Gooch, S. Chan, M. -X. Tang, X. Mao, A. P. Hays, A. G. Floyd, V. Battista, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS Neurology, April 24, 2007; 68(17): 1402 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Butman and M.K. Floeter Decreased Thickness of Primary Motor Cortex in Primary Lateral Sclerosis AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 87 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, H. Poptani, J. H. Woo, L. M. Desiderio, L. B. Elman, L. F. McCluskey, J. Krejza, and E. R. Melhem Amyotrophic Lateral Sclerosis: Diffusion-Tensor and Chemical Shift MR Imaging at 3.0 T Radiology, June 1, 2006; 239(3): 831 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaufmann, S. L. Pullman, D. C. Shungu, S. Chan, A. P. Hays, M. L. Del Bene, M. A. Dover, M. Vukic, L. P. Rowland, and H. Mitsumoto Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) Neurology, May 25, 2004; 62(10): 1753 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhai, F. Pagan, J. Statland, J. A. Butman, and M. K. Floeter Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes? Neurology, April 22, 2003; 60(8): 1258 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalra, N. R. Cashman, Z. Caramanos, A. Genge, and D. L. Arnold Gabapentin Therapy for Amyotrophic Lateral Sclerosis: Lack of Improvement in Neuronal Integrity Shown by MR Spectroscopy AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 476 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Block, F. Jessen, F. Traber, S. Flacke, C. Manka, R. Lamerichs, E. Keller, R. Heun, and H. Schild Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease Arch Neurol, May 1, 2002; 59(5): 828 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suhy, R.G. Miller, R. Rule, N. Schuff, J. Licht, V. Dronsky, D. Gelinas, A.A. Maudsley, and M.W. Weiner Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI Neurology, March 12, 2002; 58(5): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ellis, J. Suckling, E. Amaro Jr., E. T. Bullmore, A. Simmons, S. C.R. Williams, and P. N. Leigh Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS Neurology, November 13, 2001; 57(9): 1571 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Rowland and N. A. Shneider Amyotrophic Lateral Sclerosis N. Engl. J. Med., May 31, 2001; 344(22): 1688 - 1700. [Full Text] [PDF] |
||||
![]() |
B. C. Bowen and W. G. Bradley Amyotrophic Lateral Sclerosis: The Search for a Spectroscopic Marker of Upper Motoneuron Involvement Arch Neurol, May 1, 2001; 58(5): 714 - 716. [Full Text] [PDF] |
||||
![]() |
C. Pohl, W. Block, J. Karitzky, F. Traber, S. Schmidt, C. Grothe, R. Lamerichs, H. Schild, and T. Klockgether Proton Magnetic Resonance Spectroscopy of the Motor Cortex in 70 Patients With Amyotrophic Lateral Sclerosis Arch Neurol, May 1, 2001; 58(5): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mascalchi, M. Cosottini, F. Lolli, F. Salvi, C. Tessa, M. Macucci, M. Tosetti, R. Plasmati, A. Ferlini, C. A. Tassinari, et al. Proton MR Spectroscopy of the Cerebellum and Pons in Patients with Degenerative Ataxia Radiology, May 1, 2002; 223(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |